News
Detailed price information for Verve Therapeutics Inc (VERV-Q) from The Globe and Mail including charting and trades.
The primary safety risks associated with gene therapy include immune reactions and off-target effects in unintended organs, ...
Lonely Avenue,' the second single from Jon Batiste's upcoming album, is a duet that marks Randy Newman's return to the studio after years away.
A backlash against a White House video promoting deportation and Casalonga opening a new office in Düsseldorf were also among the top talking points ...
Verve Therapeutics, Inc. (NASDAQ:VERV) is one of the Stocks With Huge Catalysts on the Horizon. On April 14, Verve ...
Eli Lilly and Company has acquired Verve Therapeutics Inc., a Boston-based clinical-stage company developing genetic medicines for cardiovascular disease.
The August 1 tariff deal is approaching; however, the market seems to have gotten used to the tariff headlines.
Eli Lilly's acquisition of Vere Therapeutics promises to revolutionize cardiovascular care with innovative one-time gene ...
Eli Lilly's stock showed surprising stability, with minimal movement despite significant pipeline developments. The ...
Eli Lilly and Company (NYSE: LLY) today announced the successful completion of its acquisition of Verve Therapeutics ...
Eli Lilly and Company (NYSE: LLY) today announced the successful completion of its acquisition of Verve Therapeutics, Inc.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results